Objectives:
- Identify patients at increased risk for developing ACE-inhibitor induced angioedema and early signs and symptoms
- Explain the pathology of ACE-inhibitor induced angioedema
- Describe the evidence behind available treatment options to optimize care in patients who experience ACE-inhibitor induced angioedema
- Identify safe alternative agents that are appropriate for use in patients with a documented ACE-inhibitor allergy
Webex:
GRILL Presentation
Hosted by Christian Kroll
Tuesday, Sep 3, 2019 11:00 am | 2 hours | (UTC-06:00) Central Time (US & Canada)
Occurs every Tuesday effective 9/3/2019 until 5/26/2020 from 11:00 AM to 1:00 PM, (UTC-06:00) Central Time (US & Canada)
Meeting number: 801 212 142
Password: GRILL
https://uwhealth.webex.com/uwhealth/j.php?MTID=m5419990fae08cafb392bf19e4f6d6646
Join by video system
Dial 801212142@uwhealth.webex.com
You can also dial 173.243.2.68 and enter your meeting number.
Join by phone
+1-415-655-0003 US TOLL
Access code: 801 212 142
Session date:
09/24/2019 - 11:30am to 12:30pm CDT
Location:
G5/152
United States
See map: Google Maps
- 0.75 ACPE Contact Hours - Pharmacist
- 0.75 University of Wisconsin–Madison Continuing Education Hours
Add to calendar:
Discloser List CME Internal Report
Presenter(s):
Sydney Stiener, Pharm.D.